المؤلفون: Arrillaga-Romany I; Massachusetts General Hospital, Boston, MA., Gardner SL; New York University, Grossman School of Medicine, New York, NY., Odia Y; Miami Cancer Institute, part of Baptist Health South Florida, Miami, FL., Aguilera D; Children's Healthcare of Atlanta, Aflac Cancer and Blood Disorders Center, Emory University, Atlanta, GA., Allen JE; Chimerix, Inc, Durham, NC., Batchelor T; Dana-Farber/Brigham and Women's Cancer Center, Boston, MA., Butowski N; University of California, San Francisco, CA., Chen C; University of Minnesota Medical Center, Minneapolis, MN., Cloughesy T; University of California, Los Angeles, CA., Cluster A; Washington University of St Louis, St Louis, MO., de Groot J; University of California, San Francisco, CA., Dixit KS; Northwestern Medical Lou and Jean Malnati Brain Tumor Institute, Chicago, IL., Graber JJ; University of Washington Medical Center, Seattle, WA., Haggiagi AM; Columbia University Irving Medical Center, New York, NY., Harrison RA; BC Cancer, The University of British Columbia, Vancouver, BC, Canada., Kheradpour A; Loma Linda University, Loma Linda, CA., Kilburn LB; Children's National Hospital, Washington, DC., Kurz SC; University Hospital Tuebingen, Tuebingen, Germany., Lu G; Oncoceutics Inc, Philadelphia, PA., MacDonald TJ; Children's Healthcare of Atlanta, Aflac Cancer and Blood Disorders Center, Emory University, Atlanta, GA., Mehta M; Miami Cancer Institute, part of Baptist Health South Florida, Miami, FL., Melemed AS; Chimerix, Inc, Durham, NC., Nghiemphu PL; University of California, Los Angeles, CA., Ramage SC; Chimerix, Inc, Durham, NC., Shonka N; University of Nebraska Medical Center, Omaha, NE., Sumrall A; Levine Cancer Institute, Charlotte, NC., Tarapore RS; Chimerix, Inc, Durham, NC., Taylor L; University of Washington Medical Center, Seattle, WA., Umemura Y; University of Michigan, Ann Arbor, MI., Wen PY; Dana-Farber/Brigham and Women's Cancer Center, Boston, MA.

المصدر: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 May 01; Vol. 42 (13), pp. 1542-1552. Date of Electronic Publication: 2024 Feb 09.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Glioma*/genetics , Glioma*/drug therapy , Glioma*/pathology , Brain Neoplasms*/genetics , Brain Neoplasms*/drug therapy , Brain Neoplasms*/pathology , Mutation* , Histones*/genetics, Humans ; Adult ; Female ; Male ; Adolescent ; Middle Aged ; Young Adult ; Child ; Aged ; Neoplasm Recurrence, Local/genetics ; Neoplasm Recurrence, Local/drug therapy ; Child, Preschool ; Pyrimidines/therapeutic use ; Pyrimidines/adverse effects ; Pyridones/therapeutic use

المؤلفون: Ranjan S; Department of Neurology, Cleveland Clinic Florida, Weston, Florida, USA., Leung D; Department of Neurology, University of Michigan, Ann Arbor, Michigan, USA., Ghiaseddin AP; Department of Neurosurgery, University of Florida, Gainesville, Florida, USA., Taylor JW; Department of Neurology, University of California, San Francisco, California, USA., Lobbous M; Rose Ella Burkhardt Brain Tumor & Neuro-Oncology Center, Cleveland Clinic Foundation, Cleveland, Ohio, USA., Dhawan A; Rose Ella Burkhardt Brain Tumor & Neuro-Oncology Center, Cleveland Clinic Foundation, Cleveland, Ohio, USA., Budhu JA; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Coffee E; Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Melnick K; Department of Neurosurgery, University of Florida, Gainesville, Florida, USA., Chowdhary SA; Tampa General Hospital Cancer Institute, Tampa General Hospital, Tampa, Florida, USA., Lu-Emerson C; Department of Neurology, Maine Medical Center and Maine Health Cancer Care, Portland, Maine, USA., Kurz SC; Department of Neurology & Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Tübingen, Germany., Burke JE; Department of Neurology, Beth Israel Lahey Health, Lahey Hospital and Medical Center, Burlington, Massachusetts, USA., Lam K; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Patel MP; Preston Robert Tisch Brain Tumor Center, Duke University, Durham, North Carolina, USA., Dunbar EM; Piedmont Brain Tumor Center, Atlanta, Georgia, USA., Mohile NA; Department of Neurology, University of Rochester, Rochester, New York, USA., Peters KB; Preston Robert Tisch Brain Tumor Center, Duke University, Durham, North Carolina, USA.

المصدر: Cancer [Cancer] 2024 May 01; Vol. 130 (9), pp. 1577-1589. Date of Electronic Publication: 2024 Jan 30.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0142 (Electronic) Linking ISSN: 0008543X NLM ISO Abbreviation: Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Venous Thromboembolism*/epidemiology , Neoplasms*/drug therapy , Brain Neoplasms*/complications , Brain Neoplasms*/drug therapy, Humans ; Anticoagulants/adverse effects ; Hemorrhage ; Prospective Studies ; Neoplasm Recurrence, Local/drug therapy ; Administration, Oral

المؤلفون: Kurz SC; Department of Neurology & Interdisciplinary Neuro-Oncology, University Hospitals Tübingen, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Germany., Zan E; Department of Radiology, Weill Cornell Medicine, New York, New York., Cordova C; Cleveland Clinic Foundation Taussig Cancer Center, Cleveland, Ohio., Troxel AB; Department of Population Health, New York University Grossman School of Medicine, New York, New York., Barbaro M; Brain and Spine Tumor Center, Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York, New York., Silverman JS; Brain and Spine Tumor Center, Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York, New York.; Department of Radiation Oncology, New York University Grossman School of Medicine, New York, New York., Snuderl M; Brain and Spine Tumor Center, Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York, New York.; Department of Pathology, New York University Grossman School of Medicine, New York, New York., Zagzag D; Brain and Spine Tumor Center, Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York, New York.; Department of Pathology, New York University Grossman School of Medicine, New York, New York., Kondziolka D; Brain and Spine Tumor Center, Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York, New York.; Department of Neurosurgery, New York University Grossman School of Medicine, New York, New York., Golfinos JG; Brain and Spine Tumor Center, Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York, New York.; Department of Neurosurgery, New York University Grossman School of Medicine, New York, New York., Chi AS; Alterome Therapeutics, San Diego, California., Sulman EP; Brain and Spine Tumor Center, Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York, New York.; Department of Radiation Oncology, New York University Grossman School of Medicine, New York, New York.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Feb 16; Vol. 30 (4), pp. 680-686.

نوع المنشور: Multicenter Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Meningioma*/diagnostic imaging , Meningioma*/radiotherapy , Meningioma*/drug therapy , Organometallic Compounds*/adverse effects , Meningeal Neoplasms*/diagnostic imaging , Meningeal Neoplasms*/radiotherapy , Meningeal Neoplasms*/drug therapy , Neuroendocrine Tumors*/pathology , Receptors, Somatostatin*, Octreotide/*analogs & derivatives, Adult ; Humans ; Male ; Female ; Middle Aged ; Aged ; Radiopharmaceuticals ; Positron-Emission Tomography/methods ; Biomarkers ; Positron Emission Tomography Computed Tomography

المؤلفون: Kurz SC; Department of Neurology & Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard-Karls-University of Tübingen, Tübingen, Germany.; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany., Stammberger A; Boehringer Ingelheim Pharma GmbH & Co. KG, Ingelheim, Germany., Rosahl SK; Health and Medical University, Campus Helios Erfurt, Erfurt, Germany.; Department of Neurosurgery, Friedrich-Schiller-University Jena, Jena, Germany., Abrey LE; InCephalo Therapeutics, Allschwil, Switzerland., Albert NL; Department of Nuclear Medicine, LMU University Hospital, Ludwig-Maximilians-University, Munich, Germany., von Baumgarten L; Department of Neurology, LMU University Hospital, Ludwig-Maximilians-University, Munich, Germany., Gempt J; Department of Neurosurgery, University Hospital Hamburg Eppendorf, Hamburg, Germany., Grosu AL; Department of Radiation Oncology, Medical Center, Medical Faculty, Albert-Ludwigs-University Freiburg, Germany., Leidgens V; Novocure GmbH, Munich, Germany., McLean A; Department of Neurosurgery, Jena University Hospital, Jena, Germany., Renovanz M; Department of Neurology & Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard-Karls-University of Tübingen, Tübingen, Germany.; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany.; Department of Neurosurgery, Eberhard Karls University Tübingen, Germany., Schwarzenberger J; Novocure GmbH, Munich, Germany., Sevenich L; Institute for Tumor Biology and Experimental Therapy, Georg-Speyer-Haus, Frankfurt, Germany., Urbanic Purkart T; Department of Neurology and Department of Radiology-Division of Neuroradiology, Vascular and Interventional Neuroradiology, Medical University of Graz, Graz, Austria., Combs SE; Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Munich, Germany.; Helmholtz Zentrum München (HMGU), Oberschleißheim, Germany., Tabatabai G; Department of Neurology & Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard-Karls-University of Tübingen, Tübingen, Germany.; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany., Hegi M; Laboratory of Brain Tumour Biology and Genetics, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Nowosielski M; Department of Neurology, Medical University Innsbruck, Innsbruck, Austria.

المصدر: Neuro-oncology [Neuro Oncol] 2023 Dec 08; Vol. 25 (12), pp. 2302-2304.

نوع المنشور: Letter

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Leadership* , Medical Oncology*/organization & administration , Neurology*/organization & administration, Humans

المؤلفون: Karschnia P; From the Division of Neuro-Oncology (P.K., P.K.B., S.F.W., A.G., S.J., M.P., N.N., S.R.P., J.D.), Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurosurgery (P.K., J.-C.T.), Ludwig-Maximilians-University Munich; German Cancer Consortium (DKTK) (P.K.), Partner Site Munich; Section for Neuro-Oncology (S.C.K.), Department of Neurology, University of Tuebingen, Germany; and Department of Neurology (T.T.B.), Brigham and Woman's Hospital, Harvard Medical School, Boston, MA. p.karschnia@med.uni-muenchen.de., Kurz SC; From the Division of Neuro-Oncology (P.K., P.K.B., S.F.W., A.G., S.J., M.P., N.N., S.R.P., J.D.), Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurosurgery (P.K., J.-C.T.), Ludwig-Maximilians-University Munich; German Cancer Consortium (DKTK) (P.K.), Partner Site Munich; Section for Neuro-Oncology (S.C.K.), Department of Neurology, University of Tuebingen, Germany; and Department of Neurology (T.T.B.), Brigham and Woman's Hospital, Harvard Medical School, Boston, MA., Brastianos PK; From the Division of Neuro-Oncology (P.K., P.K.B., S.F.W., A.G., S.J., M.P., N.N., S.R.P., J.D.), Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurosurgery (P.K., J.-C.T.), Ludwig-Maximilians-University Munich; German Cancer Consortium (DKTK) (P.K.), Partner Site Munich; Section for Neuro-Oncology (S.C.K.), Department of Neurology, University of Tuebingen, Germany; and Department of Neurology (T.T.B.), Brigham and Woman's Hospital, Harvard Medical School, Boston, MA., Winter SF; From the Division of Neuro-Oncology (P.K., P.K.B., S.F.W., A.G., S.J., M.P., N.N., S.R.P., J.D.), Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurosurgery (P.K., J.-C.T.), Ludwig-Maximilians-University Munich; German Cancer Consortium (DKTK) (P.K.), Partner Site Munich; Section for Neuro-Oncology (S.C.K.), Department of Neurology, University of Tuebingen, Germany; and Department of Neurology (T.T.B.), Brigham and Woman's Hospital, Harvard Medical School, Boston, MA., Gordon A; From the Division of Neuro-Oncology (P.K., P.K.B., S.F.W., A.G., S.J., M.P., N.N., S.R.P., J.D.), Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurosurgery (P.K., J.-C.T.), Ludwig-Maximilians-University Munich; German Cancer Consortium (DKTK) (P.K.), Partner Site Munich; Section for Neuro-Oncology (S.C.K.), Department of Neurology, University of Tuebingen, Germany; and Department of Neurology (T.T.B.), Brigham and Woman's Hospital, Harvard Medical School, Boston, MA., Jones S; From the Division of Neuro-Oncology (P.K., P.K.B., S.F.W., A.G., S.J., M.P., N.N., S.R.P., J.D.), Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurosurgery (P.K., J.-C.T.), Ludwig-Maximilians-University Munich; German Cancer Consortium (DKTK) (P.K.), Partner Site Munich; Section for Neuro-Oncology (S.C.K.), Department of Neurology, University of Tuebingen, Germany; and Department of Neurology (T.T.B.), Brigham and Woman's Hospital, Harvard Medical School, Boston, MA., Pisapia M; From the Division of Neuro-Oncology (P.K., P.K.B., S.F.W., A.G., S.J., M.P., N.N., S.R.P., J.D.), Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurosurgery (P.K., J.-C.T.), Ludwig-Maximilians-University Munich; German Cancer Consortium (DKTK) (P.K.), Partner Site Munich; Section for Neuro-Oncology (S.C.K.), Department of Neurology, University of Tuebingen, Germany; and Department of Neurology (T.T.B.), Brigham and Woman's Hospital, Harvard Medical School, Boston, MA., Nayyar N; From the Division of Neuro-Oncology (P.K., P.K.B., S.F.W., A.G., S.J., M.P., N.N., S.R.P., J.D.), Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurosurgery (P.K., J.-C.T.), Ludwig-Maximilians-University Munich; German Cancer Consortium (DKTK) (P.K.), Partner Site Munich; Section for Neuro-Oncology (S.C.K.), Department of Neurology, University of Tuebingen, Germany; and Department of Neurology (T.T.B.), Brigham and Woman's Hospital, Harvard Medical School, Boston, MA., Tonn JC; From the Division of Neuro-Oncology (P.K., P.K.B., S.F.W., A.G., S.J., M.P., N.N., S.R.P., J.D.), Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurosurgery (P.K., J.-C.T.), Ludwig-Maximilians-University Munich; German Cancer Consortium (DKTK) (P.K.), Partner Site Munich; Section for Neuro-Oncology (S.C.K.), Department of Neurology, University of Tuebingen, Germany; and Department of Neurology (T.T.B.), Brigham and Woman's Hospital, Harvard Medical School, Boston, MA., Batchelor TT; From the Division of Neuro-Oncology (P.K., P.K.B., S.F.W., A.G., S.J., M.P., N.N., S.R.P., J.D.), Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurosurgery (P.K., J.-C.T.), Ludwig-Maximilians-University Munich; German Cancer Consortium (DKTK) (P.K.), Partner Site Munich; Section for Neuro-Oncology (S.C.K.), Department of Neurology, University of Tuebingen, Germany; and Department of Neurology (T.T.B.), Brigham and Woman's Hospital, Harvard Medical School, Boston, MA., Plotkin SR; From the Division of Neuro-Oncology (P.K., P.K.B., S.F.W., A.G., S.J., M.P., N.N., S.R.P., J.D.), Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurosurgery (P.K., J.-C.T.), Ludwig-Maximilians-University Munich; German Cancer Consortium (DKTK) (P.K.), Partner Site Munich; Section for Neuro-Oncology (S.C.K.), Department of Neurology, University of Tuebingen, Germany; and Department of Neurology (T.T.B.), Brigham and Woman's Hospital, Harvard Medical School, Boston, MA., Dietrich J; From the Division of Neuro-Oncology (P.K., P.K.B., S.F.W., A.G., S.J., M.P., N.N., S.R.P., J.D.), Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston; Department of Neurosurgery (P.K., J.-C.T.), Ludwig-Maximilians-University Munich; German Cancer Consortium (DKTK) (P.K.), Partner Site Munich; Section for Neuro-Oncology (S.C.K.), Department of Neurology, University of Tuebingen, Germany; and Department of Neurology (T.T.B.), Brigham and Woman's Hospital, Harvard Medical School, Boston, MA.

المصدر: Neurology [Neurology] 2023 Oct 24; Vol. 101 (17), pp. e1741-e1746. Date of Electronic Publication: 2023 Aug 01.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0401060 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1526-632X (Electronic) Linking ISSN: 00283878 NLM ISO Abbreviation: Neurology Subsets: MEDLINE

مواضيع طبية MeSH: Methotrexate*/adverse effects , Lymphoma*/drug therapy , Lymphoma*/genetics, Humans ; Methylenetetrahydrofolate Reductase (NADPH2)/genetics ; Retrospective Studies ; Folic Acid ; Genotype

المؤلفون: Galbraith K; Department of Pathology, NYU Langone Health, New York, Department of Pathology, NYU Langone, New York, USA., Vasudevaraja V; Department of Pathology, NYU Langone Health, New York, Department of Pathology, NYU Langone, New York, USA., Serrano J; Department of Pathology, NYU Langone Health, New York, Department of Pathology, NYU Langone, New York, USA., Shen G; Department of Pathology, NYU Langone Health, New York, Department of Pathology, NYU Langone, New York, USA., Tran I; Department of Pathology, NYU Langone Health, New York, Department of Pathology, NYU Langone, New York, USA., Abdallat N; Department of Pathology, NYU Langone Health, New York, Department of Pathology, NYU Langone, New York, USA., Wen M; Department of Pathology, NYU Langone Health, New York, Department of Pathology, NYU Langone, New York, USA., Patel S; Department of Pathology, NYU Langone Health, New York, Department of Pathology, NYU Langone, New York, USA., Movahed-Ezazi M; Department of Pathology, NYU Langone Health, New York, Department of Pathology, NYU Langone, New York, USA., Faustin A; Department of Pathology, NYU Langone Health, New York, Department of Pathology, NYU Langone, New York, USA., Spino-Keeton M; Department of Pathology, NYU Langone Health, New York, Department of Pathology, NYU Langone, New York, USA., Roberts LG; Department of Pathology, NYU Langone Health, New York, Department of Pathology, NYU Langone, New York, USA., Maloku E; Department of Pathology, NYU Langone Health, New York, Department of Pathology, NYU Langone, New York, USA., Drexler SA; Department of Pathology and Laboratory Medicine, NYU, Mineola, New York, USA.; Current affiliations: Department of Pathology, Mount Sinai South Nassau Hospital, Oceanside, New York, USA., Liechty BL; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College - New York Presbyterian Hospital, New York, New York, USA., Pisapia D; Department of Pathology and Laboratory Medicine, Weill Cornell Medical College - New York Presbyterian Hospital, New York, New York, USA., Krasnozhen-Ratush O; Department of Pathology and Laboratory Medicine, Baystate Health, Springfield, Massachusetts, USA., Rosenblum M; Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Shroff S; Department of Pathology and Laboratory Medicine, AdventHealth Orlando, Orlando, Florida, USA., Boué DR; Department of Pathology and Laboratory Medicine, Nationwide Children's Hospital, and the Ohio State University, Columbus, Ohio, USA., Davidson C; Department of Pathology, University of Utah, Salt Lake City, Utah, USA., Mao Q; Department of Pathology, University of Utah, Salt Lake City, Utah, USA., Suchi M; Department of Pathology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., North P; Department of Pathology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Hopp A, Segura A; Department of Pathology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Jarzembowski JA; Department of Pathology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Parsons L; Department of Pathology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA., Johnson MD; Department of Pathology, University of Rochester School of Medicine, New York, USA., Mobley B; Department of Pathology, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Samore W; Department of Pathology, Advocate Aurora Health, Chicago, Illinois, USA., McGuone D; Department of Pathology, Yale University School of Medicine, Connecticut, USA., Gopal PP; Department of Pathology, Yale University School of Medicine, Connecticut, USA., Canoll PD; Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, USA., Horbinski C; Departments of Pathology and Neurosurgery, Feinberg School of Medicine, Northwestern University, Illinois, USA., Fullmer JM; Department of Pathology, Beaumont Hospital, Royal Oak, Michigan, USA., Farooqui MS; Department of Pathology and Laboratory Medicine, Children's Mercy Kansas City, Kansas City, Missouri, USA., Gokden M; Department of Pathology, University of Arkansas and Arkansas Children's Hospital, Little Rock, Arkansas, USA., Wadhwani NR; Department of Pathology and Laboratory Medicine, Ann and Robert H. Lurie Children's Hospital of Chicago, Illinois, USA., Richardson TE; Department of Pathology and Laboratory Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Umphlett M; Department of Pathology and Laboratory Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Tsankova NM; Department of Pathology and Laboratory Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, USA., DeWitt JC; Department of Pathology, University of Vermont Medical Center., Sen C; Department of Neurosurgery, NYU Langone, New York, New York, USA., Placantonakis DG; Department of Neurosurgery, NYU Langone, New York, New York, USA., Pacione D; Department of Neurosurgery, NYU Langone, New York, New York, USA., Wisoff JH; Department of Neurosurgery, NYU Langone, New York, New York, USA., Teresa Hidalgo E; Department of Neurosurgery, NYU Langone, New York, New York, USA., Harter D; Department of Neurosurgery, NYU Langone, New York, New York, USA., William CM; Department of Pathology, NYU Langone Health, New York, Department of Pathology, NYU Langone, New York, USA., Cordova C; Department of Neuro-oncology, NYU Langone, New York, New York, USA.; Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, OH., Kurz SC; Department of Neuro-oncology, NYU Langone, New York, New York, USA.; Department of Interdisciplinary Neuro-Oncology, Comprehensive Cancer Center, University of Tuebingen, Tübingen, Germany., Barbaro M; Department of Neuro-oncology, NYU Langone, New York, New York, USA., Orringer DA; Department of Neurosurgery, NYU Langone, New York, New York, USA., Karajannis MA; Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, New York, USA., Sulman EP; Department of Radiation Oncology, NYU Langone, New York, New York, USA., Gardner SL; Department of Pediatrics, NYU Langone, New York, New York, USA., Zagzag D; Department of Pathology, NYU Langone Health, New York, Department of Pathology, NYU Langone, New York, USA.; Department of Neurosurgery, NYU Langone, New York, New York, USA., Tsirigos A; Applied Bioinformatics Laboratories, NYU Langone, New York, New YorkUSA., Allen JC; Department of Pediatrics, NYU Langone, New York, New York, USA., Golfinos JG; Department of Neurosurgery, NYU Langone, New York, New York, USA., Snuderl M; Department of Pathology, NYU Langone Health, New York, Department of Pathology, NYU Langone, New York, USA.; Laura and Isaac Perlmutter Cancer Center, New York, New York, USA.

المصدر: Neuro-oncology advances [Neurooncol Adv] 2023 Jun 26; Vol. 5 (1), pp. vdad076. Date of Electronic Publication: 2023 Jun 26 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE

المؤلفون: Renovanz M; Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Germany.; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany.; Department of Neurosurgery, Eberhard Karls University Tübingen, Germany., Kurz SC; Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Germany.; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany., Rieger J; Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Germany.; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany., Walter B; Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Germany., Becker H; Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Germany.; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany.; Department of Neurosurgery, Eberhard Karls University Tübingen, Germany., Hille H; Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Germany., Bombach P; Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Germany.; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany.; Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany., Rieger D; Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Germany.; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany., Grosse L; Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Germany.; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany., Häusser L; Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Germany.; German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Eberhard Karls University of Tübingen, Germany., Skardelly M; Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Germany.; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany., Merk DJ; Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Germany., Paulsen F; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany.; Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.; Department of Radiation Oncology, Eberhard Karls University Tübingen, Germany., Hoffmann E; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany.; Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.; Department of Radiation Oncology, Eberhard Karls University Tübingen, Germany., Gani C; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany.; Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.; Department of Radiation Oncology, Eberhard Karls University Tübingen, Germany.; German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Eberhard Karls University of Tübingen, Germany., Neumann M; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany.; Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.; Institute of Pathology and Neuropathology, Department of Neuropathology, Eberhard Karls University Tübingen, Germany.; German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Eberhard Karls University of Tübingen, Germany., Beschorner R; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany.; Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.; Institute of Pathology and Neuropathology, Department of Neuropathology, Eberhard Karls University Tübingen, Germany.; German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Eberhard Karls University of Tübingen, Germany., Rieß O; Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.; Institute of Medical Genetics and Applied Genomics, Eberhard Karls University Tübingen, Germany.; Cluster of Excellence (EXC 2180) 'Image Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University of Tübingen, Germany.; German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Eberhard Karls University of Tübingen, Germany., Roggia C; Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.; Institute of Medical Genetics and Applied Genomics, Eberhard Karls University Tübingen, Germany., Schroeder C; Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.; Institute of Medical Genetics and Applied Genomics, Eberhard Karls University Tübingen, Germany., Ossowski S; Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.; Institute of Medical Genetics and Applied Genomics, Eberhard Karls University Tübingen, Germany., Armeanu-Ebinger S; Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.; Institute of Medical Genetics and Applied Genomics, Eberhard Karls University Tübingen, Germany., Gschwind A; Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.; Institute of Medical Genetics and Applied Genomics, Eberhard Karls University Tübingen, Germany., Biskup S; Center for Genomics and Transcriptomics (CeGaT) & Center for Human Genetics Tübingen, Germany.; Cluster of Excellence (EXC 2180) 'Image Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University of Tübingen, Germany., Schulze M; Center for Genomics and Transcriptomics (CeGaT) & Center for Human Genetics Tübingen, Germany., Fend F; Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.; Department of Pathology and Neuropathology, Institute of Pathology and Molecular Pathology, Eberhard Karls University Tübingen, Germany.; Cluster of Excellence (EXC 2180) 'Image Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University of Tübingen, Germany.; German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Eberhard Karls University of Tübingen, Germany., Singer S; Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.; Department of Pathology and Neuropathology, Institute of Pathology and Molecular Pathology, Eberhard Karls University Tübingen, Germany.; Cluster of Excellence (EXC 2180) 'Image Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University of Tübingen, Germany.; German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Eberhard Karls University of Tübingen, Germany., Zender L; Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.; Department of Medical Oncology and Pneumology (Internal Medicine VIII), Eberhard Karls University Tübingen, Germany.; Cluster of Excellence (EXC 2180) 'Image Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University of Tübingen, Germany.; German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Eberhard Karls University of Tübingen, Germany., Lengerke C; Department of Internal Medicine II, Eberhard Karls University Tübingen, Germany.; German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Eberhard Karls University of Tübingen, Germany., Brucker SY; Department of Gynecology and Obstetrics, Eberhard Karls University Tübingen, Germany.; German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Eberhard Karls University of Tübingen, Germany., Engler T; Department of Gynecology and Obstetrics, Eberhard Karls University Tübingen, Germany.; German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Eberhard Karls University of Tübingen, Germany., Forschner A; Department of Dermatology and Center for Dermato-Oncology, Eberhard Karls University Tübingen, Germany.; German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Eberhard Karls University of Tübingen, Germany., Stenzl A; Department of Urology, Eberhard Karls University Tübingen, Germany.; German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Eberhard Karls University of Tübingen, Germany., Kohlbacher O; Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.; Institute for Translational Bioinformatics, Eberhard Karls University Tübingen, Germany.; German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Eberhard Karls University of Tübingen, Germany., Nahnsen S; Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.; Quantitative Biology Center (QBiC), Eberhard Karls University Tübingen, Germany.; Department of Medical Oncology and Pneumology (Internal Medicine VIII), Eberhard Karls University Tübingen, Germany.; Cluster of Excellence (EXC 2180) 'Image Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University of Tübingen, Germany.; German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Eberhard Karls University of Tübingen, Germany., Gabernet G; Quantitative Biology Center (QBiC), Eberhard Karls University Tübingen, Germany., Fillinger S; Quantitative Biology Center (QBiC), Eberhard Karls University Tübingen, Germany., Bender B; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany.; Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.; Department of Diagnostic and Interventional Neuroradiology, Department of Radiology, Eberhard Karls University Tübingen, Germany., Ernemann U; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany.; Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.; Department of Diagnostic and Interventional Neuroradiology, Department of Radiology, Eberhard Karls University Tübingen, Germany., Öner Ö; Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany., Beha J; Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany., Malek HS; Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany., Möller Y; Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany., Ruhm K; Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany., Tatagiba M; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany.; Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.; Department of Neurosurgery, Eberhard Karls University Tübingen, Germany., Schittenhelm J; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany.; Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.; Institute of Pathology and Neuropathology, Department of Neuropathology, Eberhard Karls University Tübingen, Germany.; German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Eberhard Karls University of Tübingen, Germany., Bitzer M; Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.; Department of Internal Medicine I, Eberhard Karls University Tübingen, Germany.; Cluster of Excellence (EXC 2180) 'Image Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University of Tübingen, Germany.; German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Eberhard Karls University of Tübingen, Germany., Malek N; Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.; Department of Internal Medicine I, Eberhard Karls University Tübingen, Germany.; Cluster of Excellence (EXC 2180) 'Image Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University of Tübingen, Germany.; German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Eberhard Karls University of Tübingen, Germany., Zips D; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany.; Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.; Department of Radiation Oncology, Eberhard Karls University Tübingen, Germany.; German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Eberhard Karls University of Tübingen, Germany., Tabatabai G; Department of Neurology and Interdisciplinary Neuro-Oncology, Hertie Institute for Clinical Brain Research, Eberhard Karls University Tübingen, Germany.; Center for Neuro-Oncology, Comprehensive Cancer Center Tübingen-Stuttgart, University Hospital Tübingen, Germany.; Center for Personalized Medicine Tübingen, Eberhard Karls University Tübingen, Germany.; Cluster of Excellence (EXC 2180) 'Image Guided and Functionally Instructed Tumor Therapies', Eberhard Karls University of Tübingen, Germany.; German Cancer Consortium (DKTK), DKFZ partner site Tübingen, Eberhard Karls University of Tübingen, Germany.

المصدر: Neuro-oncology advances [Neurooncol Adv] 2023 Feb 14; Vol. 5 (1), pp. vdad012. Date of Electronic Publication: 2023 Feb 14 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE

المؤلفون: Liu EK; NYU Grossman School of Medicine, New York, NY, USA., Vasudevaraja V; NYU Grossman School of Medicine, New York, NY, USA.; Department of Pathology, NYU Langone Health, New York, NY, USA., Sviderskiy VO; NYU Grossman School of Medicine, New York, NY, USA.; Department of Pathology, NYU Langone Health, New York, NY, USA., Feng Y; Department of Biostatistics, NYU School of Global Public Health, New York, NY, USA., Tran I; NYU Grossman School of Medicine, New York, NY, USA.; Department of Pathology, NYU Langone Health, New York, NY, USA., Serrano J; NYU Grossman School of Medicine, New York, NY, USA.; Department of Pathology, NYU Langone Health, New York, NY, USA., Cordova C; NYU Grossman School of Medicine, New York, NY, USA.; Department of Neurology, NYU Langone Health, New York, NY, USA.; The Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York, NY, USA., Kurz SC; NYU Grossman School of Medicine, New York, NY, USA.; Department of Neurology, NYU Langone Health, New York, NY, USA.; The Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York, NY, USA., Golfinos JG; NYU Grossman School of Medicine, New York, NY, USA.; Department of Neurosurgery, NYU Langone Health, New York, NY, USA.; The Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York, NY, USA., Sulman EP; NYU Grossman School of Medicine, New York, NY, USA.; Department of Radiation Oncology, New York, NY, USA.; The Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York, NY, USA., Orringer DA; NYU Grossman School of Medicine, New York, NY, USA.; Department of Neurosurgery, NYU Langone Health, New York, NY, USA.; The Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York, NY, USA., Placantonakis D; NYU Grossman School of Medicine, New York, NY, USA.; Department of Neurosurgery, NYU Langone Health, New York, NY, USA.; The Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York, NY, USA., Possemato R; NYU Grossman School of Medicine, New York, NY, USA.; Department of Pathology, NYU Langone Health, New York, NY, USA.; The Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York, NY, USA., Snuderl M; NYU Grossman School of Medicine, New York, NY, USA.; Department of Pathology, NYU Langone Health, New York, NY, USA.; The Laura and Isaac Perlmutter Cancer Center at NYU Langone Health, New York, NY, USA.

المصدر: Neuro-oncology advances [Neurooncol Adv] 2022 Oct 11; Vol. 4 (1), pp. vdac163. Date of Electronic Publication: 2022 Oct 11 (Print Publication: 2022).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE

المؤلفون: Sabari JK; Laura and Isaac Perlmutter Cancer Center, NYU Langone, New York, New York., Velcheti V; Laura and Isaac Perlmutter Cancer Center, NYU Langone, New York, New York., Shimizu K; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Tokyo Medical and Dental University, Tokyo, Japan., Strickland MR; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.; Dana-Farber Cancer Institute, Boston, Massachusetts., Heist RS; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Singh M; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Nayyar N; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Giobbie-Hurder A; Dana-Farber Cancer Institute, Boston, Massachusetts., Digumarthy SR; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Gainor JF; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Rajan AP; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Nieblas-Bedolla E; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Burns AC; Mirati Therapeutics, Inc., San Diego, California., Hallin J; Mirati Therapeutics, Inc., San Diego, California., Olson P; Mirati Therapeutics, Inc., San Diego, California., Christensen JG; Mirati Therapeutics, Inc., San Diego, California., Kurz SC; Laura and Isaac Perlmutter Cancer Center, NYU Langone, New York, New York., Brastianos PK; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts., Wakimoto H; Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.

المصدر: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Aug 02; Vol. 28 (15), pp. 3318-3328.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Brain Neoplasms*/drug therapy , Brain Neoplasms*/genetics , Brain Neoplasms*/mortality , Carcinoma, Non-Small-Cell Lung*/drug therapy , Carcinoma, Non-Small-Cell Lung*/genetics , Carcinoma, Non-Small-Cell Lung*/pathology , Lung Neoplasms*/drug therapy , Lung Neoplasms*/genetics , Lung Neoplasms*/pathology, Acetonitriles ; Animals ; Humans ; Mice ; Piperazines ; Proto-Oncogene Proteins p21(ras)/genetics ; Pyrimidines ; Retrospective Studies

المؤلفون: de Groot JF; Department of Neuro-Oncology, UCSF Weill Institute for Neurosciences, San Francisco, California,USA., Kim AH; Department of Neurosurgery, Washington University School of Medicine, St. Louis, Missouri, USA., Prabhu S; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Rao G; Department of Neurosurgery, Baylor College of Medicine, Houston, Texas, USA., Laxton AW; Department of Neurosurgery, Wake Forest Baptist Health, Winston-Salem, North Carolina, USA., Fecci PE; Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina, USA., O'Brien BJ; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Sloan A; Department of Neurosurgery, University Hospitals-Cleveland Medical Center & Seidman Cancer Center, Cleveland, Ohio, USA., Chiang V; Department of Neurosurgery, Yale School of Medicine, New Haven, Connecticut, USA., Tatter SB; Department of Neurosurgery, Wake Forest Baptist Health, Winston-Salem, North Carolina, USA., Mohammadi AM; Department of Neurosurgery, Cleveland Clinic Lerner College of Medicine at CWRU, Cleveland, Ohio, USA., Placantonakis DG; Department of Neurosurgery, NYU Grossman School of Medicine, New York, New York, USA., Strowd RE; Department of Neuro-Oncology, Wake Forest Baptist Health, Winston- Salem, North Carolina, USA., Chen C; Department of Neurosurgery, University of Minnesota Medical Center, Minneapolis, Minnesota, USA., Hadjipanayis C; Department of Neurosurgery, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Khasraw M; Department of Neuro-Oncology, Duke University Medical Center, Durham, North Carolina, USA., Sun D; Department of Neurosurgery, Norton Neuroscience Institute, Louisville, Kentucky, USA., Piccioni D; Department of Neuro-Oncology, University of California San Diego Health, La Jolla, California, USA., Sinicrope KD; Department of Neuro-Oncology, Norton Neuroscience Institute, Louisville, Kentucky, USA., Campian JL; Department of Neuro-Oncology, Mayo Clinic, Rochester, Minnesota, USA., Kurz SC; Department of Neuro-Oncology, NYU Langone Perlmutter Cancer Center, New York, New York, USA., Williams B; Department of Neurosurgery, University of Louisville Health, Louisville, Kentucky, USA., Smith K; Department of Neurosurgery, Barrow Neurological Institute, Phoenix, Arizona, USA., Tovar-Spinoza Z; Department of Neurosurgery, SUNY Upstate Medical University, Syracuse, New York, USA., Leuthardt EC; Department of Neurosurgery, Washington University School of Medicine, St. Louis, Missouri, USA.

المصدر: Neuro-oncology advances [Neurooncol Adv] 2022 Apr 06; Vol. 4 (1), pp. vdac040. Date of Electronic Publication: 2022 Apr 06 (Print Publication: 2022).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE